Cargando…

Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis

INTRODUCTION: The incidence of cardiovascular diseases (CVD) is increased in rheumatoid arthritis (RA) patients. It remains unclear whether the load of RA increases cardiovascular (CV) risk especially in female and in younger RA patients. In the present study we aim to analyse the influence of age a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fransen, Jaap, Kazemi-Bajestani, Seyyed M. R., Bredie, Sebastian J. H., Popa, Calin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911000/ https://www.ncbi.nlm.nih.gov/pubmed/27310259 http://dx.doi.org/10.1371/journal.pone.0157360

Ejemplares similares

Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study
por: Rohrich, Daphne C., et al.
Publicado: (2021)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
por: Arts, Elke, et al.
Publicado: (2012)

Current Status of Publications of Cardiovascular Interventions in Iran; a PubMed-Based Study
por: Ebrahimi, Mahmoud, et al.
Publicado: (2012)

Concept of Atherosclerosis Velocity: Is It a Better Measure of Cardiovascular Risk?
por: Kazemi-Bajestani, Seyyed Mohammad Reza, et al.
Publicado: (2013)

Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management
por: Dessein, Patrick H., et al.
Publicado: (2015)

Atherosclerosis in Rheumatoid Arthritis
por: González-Gay, Miguel A., et al.
Publicado: (2012)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Relationship Between Serum Vitamin D Level and Disease Severity in Rheumatoid Arthritis
por: Soltani Bajestani, Farhang, et al.
Publicado: (2023)

Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Lyu, Qian, et al.
Publicado: (2023)

Cardiovascular Disease and the Female Disadvantage
por: Woodward, Mark
Publicado: (2019)

Serum Samples That Have Been Stored Long-Term (>10 Years) Can Be Used as a Suitable Data Source for Developing Cardiovascular Risk Prediction Models in Large Observational Rheumatoid Arthritis Cohorts
por: Arts, Elke E. A., et al.
Publicado: (2014)

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
por: Hendrikx, Jos, et al.
Publicado: (2016)

The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries
por: Hewlett, Sarah, et al.
Publicado: (2018)

Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease-
por: Oyama, Jun-ichi, et al.
Publicado: (2019)

IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis
por: Damen, Michelle S. M. A., et al.
Publicado: (2017)

Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2012)

Management of Cardiovascular Disease Risk in Rheumatoid Arthritis
por: Dessein, Patrick H., et al.
Publicado: (2022)

Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis
por: Toonen, Erik JM, et al.
Publicado: (2012)

Comparison of Biologic Discontinuation in Patients With Elderly‐Onset Versus Younger‐Onset Rheumatoid Arthritis
por: Richter, Michael D., et al.
Publicado: (2019)

Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
por: Gouze, Hélène, et al.
Publicado: (2022)

Lipid Clinics Are Urgently Required in the Iranian Public Health System
por: Ghayour-Mobarhan, Majid, et al.
Publicado: (2010)

Monitoring rheumatoid arthritis using an algorithm based on patient-reported outcome measures: a first step towards personalised healthcare
por: Hendrikx, Jos, et al.
Publicado: (2015)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022)

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

Cardiovascular risk score in Rheumatoid Arthritis
por: Wagan, Abrar Ahmed, et al.
Publicado: (2016)

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
por: Li, Xiuying, et al.
Publicado: (2022)

Cardiovascular Disease in Rheumatoid Arthritis: A Systematic Literature Review in Latin America
por: Sarmiento-Monroy, Juan Camilo, et al.
Publicado: (2012)

Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
por: Sun, Kai-jun, et al.
Publicado: (2021)

The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Chen, Yuehong, et al.
Publicado: (2021)

Outcome of unlinked total elbow arthroplasty for rheumatoid arthritis in patients younger than 50 years old
por: Nishida, Keiichiro, et al.
Publicado: (2023)

Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis
por: Curran, Samuel A., et al.
Publicado: (2014)

Utility of different cardiovascular disease prediction models in rheumatoid arthritis
por: Purcarea, A, et al.
Publicado: (2014)

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2018)

Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis
por: Södergren, Anna, et al.
Publicado: (2019)

Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
por: DeMizio, Daniel J., et al.
Publicado: (2019)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
por: Aronov, Avi, et al.
Publicado: (2022)

Prevalence and influence of hypouricemia on cardiovascular diseases in patients with rheumatoid arthritis
por: Zou, Yao-Wei, et al.
Publicado: (2022)

Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study
por: Sluijsmans, Dorien M. C. F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jab6lmssbc1k75p9rlomhkf3e